Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-06-15 7:13 pm Sale | 13D | APREA THERAPEUTICS INC APRE | 5AM Ventures IV L.P. | 2,352,654 11.2% | -244,999 (-9.43%) | View |
2020-05-21 8:38 pm Sale | 13D | APREA THERAPEUTICS INC APRE | 5AM Ventures IV L.P. | 2,597,653 12.3% | -255,000 (-8.94%) | View |
2020-02-14 2:46 pm Purchase | 13G | APREA THERAPEUTICS INC APRE | JANUS HENDERSON GROUP PLC JHG | 1,810,859 8.6% | 1,810,859 (New Position) | View |
2020-02-14 08:00 am Purchase | 13G | APREA THERAPEUTICS INC APRE | KDev Investments AB | 2,444,837 11.6% | 2,444,837 (New Position) | View |
2020-02-13 08:34 am Purchase | 13G | APREA THERAPEUTICS INC APRE | SECTORAL ASSET MANAGEMENT INC | 1,470,339 7% | 1,470,339 (New Position) | View |
2020-02-07 11:12 am Purchase | 13G | APREA THERAPEUTICS INC APRE | FMR LLC | 2,142,428 10.206% | 131,879 (+6.56%) | View |
2019-11-12 12:12 pm Purchase | 13G | APREA THERAPEUTICS INC APRE | FMR LLC | 2,010,549 10.115% | 2,010,549 (New Position) | View |
2019-10-18 3:23 pm Purchase | 13G | APREA THERAPEUTICS INC APRE | Versant Ventures V LLC | 2,519,323 12.1% | 2,519,323 (New Position) | View |
2019-10-18 09:22 am Purchase | 13D | APREA THERAPEUTICS INC APRE | HealthCap VII L.P. | 2,366,104 11.9% | 2,366,104 (New Position) | View |
2019-10-17 5:29 pm Purchase | 13D | APREA THERAPEUTICS INC APRE | 5AM Ventures IV L.P. | 2,852,653 13.8% | 2,852,653 (New Position) | View |
2019-10-11 4:10 pm Purchase | 13G | APREA THERAPEUTICS INC APRE | Rock Springs Capital Management LP | 925,000 4.46% | 925,000 (New Position) | View |
2019-10-08 8:13 pm Purchase | 13G | APREA THERAPEUTICS INC APRE | Redmile Group LLC | 2,268,718 10.9% | 2,268,718 (New Position) | View |